J&J unit ordered to pay $8b in anti-psychotic drug case
Bloomberg Johnson & Johnson’s Janssen unit was hit with an $8 billion punitive-damages verdict — the largest jury award in the US this year — over its alleged mishandling of an anti-psychotic drug blamed for disfiguring the physique of adolescent boys. A state court jury in Philadelphia concluded the Janssen’s wrongful marketing of its Risperdal drug to teens warranted the ...
Read More »